1. Pink Sheet

Merck's Ebola Vaccine Will Get US FDA Decision Before March Review Deadline

 
• By Brenda Sandburg

Staffer says agency will make a licensure decision "well ahead" of the March action date; 230,000 have received the vaccine under compassionate use.

Fake ebola vaccine vial with syringe and stethoscope at the background - Image
Merck's Ebola Vaccine Application Is Getting Speedy FDA Review

The US Food and Drug Administration plans to complete review of Merck & Co. Inc.'s Ebola vaccine application before its March 14 user fee date.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Vaccines

More from Pink Sheet